NCT07149688 Village-Based Management of Chronic Cardiovascular Disease in Qu Jiang Elderly Population Registry: The BOUQUET Cohort Study
| NCT ID | NCT07149688 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Anzhen Hospital |
| Condition | Atrial Fibrillation (AF) |
| Study Type | OBSERVATIONAL |
| Enrollment | 30,000 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2035-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30,000 participants in total. It began in 2024-03-01 with a primary completion date of 2035-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective observational cohort study conducted in Qujiang District, Zhejiang Province, China, aiming to evaluate the effectiveness of a comprehensive management program for elderly patients with chronic cardiovascular diseases (CVDs). The program integrates pharmacological treatment, lifestyle modification, health education, and long-term follow-up, with enhanced monitoring using 7-day ECG recording. The study focuses on major chronic CVDs including hypertension, coronary artery disease, atrial fibrillation, and heart failure. Approximately 30,000 participants aged ≥60 years will be enrolled and followed for up to 10 years.
Eligibility Criteria
Inclusion Criteria Age ≥60 years Resident of Qujiang District Diagnosed with chronic CVD (hypertension, coronary artery disease, heart failure, atrial fibrillation, or others) Able and willing to provide informed consent Exclusion Criteria Severe cognitive impairment or inability to provide consent Life expectancy \<1 year due to non-cardiovascular disease Participation refusal
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07149688 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Atrial Fibrillation (AF). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07149688 currently recruiting?
Yes, NCT07149688 is actively recruiting participants. Contact the research team at 13840293506@163.com for enrollment information.
Where is the NCT07149688 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT07149688 clinical trial?
NCT07149688 is sponsored by Beijing Anzhen Hospital. The trial plans to enroll 30,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.